Foresite Capital Management V, LLC - Q1 2023 holdings

$135 Million is the total value of Foresite Capital Management V, LLC's 11 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .

 Value Shares↓ Weighting
HIMS SellHims & Hers Health, Inc.$37,035,140
+43.0%
3,733,381
-7.6%
27.38%
+36.1%
 Theseus Pharmaceuticals, Inc.$31,837,872
+78.3%
3,585,3460.0%23.54%
+69.7%
 Pardes Biosciences Inc$13,250,074
-21.9%
10,037,9350.0%9.80%
-25.7%
KNTE BuyKinnate Biopharma Inc.$12,343,756
+131.3%
1,975,001
+125.7%
9.12%
+120.1%
CMPX SellCompass Therapeutics, Inc.$11,381,964
-48.6%
3,480,723
-20.9%
8.41%
-51.1%
ACRS  Aclaris Therapeutics, Inc.$10,179,186
-48.6%
1,258,2430.0%7.52%
-51.1%
 Somalogic, Inc.$8,967,004
+1.6%
3,516,4720.0%6.63%
-3.3%
 Disc Medicine, Inc.$5,160,040
+6.5%
243,5130.0%3.81%
+1.4%
ACET  Adicet Bio, Inc.$3,217,743
-35.6%
558,6360.0%2.38%
-38.7%
QSI BuyQuantum Si Inc$1,626,951
-3.8%
924,404
+0.0%
1.20%
-8.4%
PHVS  Pharvaris N.V.$275,014
-28.4%
34,1420.0%0.20%
-31.9%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Kinnate Biopharma Inc.12Q3 202325.8%
Hims & Hers Health, Inc.11Q3 202337.5%
Aclaris Therapeutics, Inc.11Q3 202315.4%
Pharvaris N.V.11Q3 20235.5%
Quantum-Si Incorporated9Q2 202311.3%
TheseusPharmaceuticals, Inc.8Q3 202324.4%
Somalogic, Inc.8Q2 202320.5%
Compass Therapeutics, Inc.8Q3 202317.2%
Pardes Biosciences Inc7Q2 202337.8%
Gemini Therapeutics, Inc.7Q3 20229.7%

View Foresite Capital Management V, LLC's complete holdings history.

Latest filings
TypeFiled
42024-04-05
13F-HR2024-02-13
13F-HR2023-11-13
42023-08-31
13F-HR2023-08-11
42023-07-19
13F-HR2023-05-12
42023-05-10
42023-04-06
42023-02-22

View Foresite Capital Management V, LLC's complete filings history.

Compare quarters

Export Foresite Capital Management V, LLC's holdings